Rena Hirani Awarded the Inaugural James Isbister Prize at the Blood ISBT 2025
Rena Hirani, Senior Research Fellow at the Australian Red Cross Lifeblood, shared on LinkedIn:
”Following a big week of wins, I am thrilled to share yet more exciting news.
I was awarded the inaugural James Isbister Prize at the recent Blood ISBT 2025 Conference in Perth.
This honour marks a significant milestone in my research career, and I’m deeply grateful for the recognition.
Professor James Isbister is a pioneering figure in haematology, transfusion medicine and medical education.
His work shaped global standards in patient blood management.
Prof. Isbister completed his postgraduate training in internal medicine at St Vincent’s Hospital.
He was part of a team that performed the first successful Australian allogeneic bone marrow transplants, which is now commonly used to treat blood cancers.
Transfusion medicine became his passion since every speciality involves blood.
This prize, named after him in honour of his achievements to Australian medicine, was awarded for significant contributions in research into blood and blood products, education of the medical community and encouragement of appropriate clinical use of blood and plasma products for better healthcare.
The occasion was made even more memorable by the fact that James, energetically in his 80s, was present to award me personally which was a deeply meaningful honour.
I would also like to recognise the long term support of my work by Australian Red Cross Lifeblood, ANZSBT and National Blood Authority, Australia.
It is a true privilege to be a part of the transfusion community.”
More winner stories featured in Hemostasis Today.
-
Nov 1, 2025, 18:00Kathleen Freson to Speak at the EHA SWG Scientific Meeting
-
Nov 1, 2025, 17:38Joshua Muia on Genetic Alterations Affecting ADAMTS13 Maturation at IPS 2025
-
Nov 1, 2025, 17:19Michael Makris Shares 2024 Annual Global Survey from the WFH
-
Nov 1, 2025, 16:45Erin VanDyke: This Month Was Full of Meaningful VTE Moments
-
Nov 1, 2025, 14:14Congratulations to South Africa’s first WSO Certified Essential Stroke Centers!
-
Oct 31, 2025, 13:47Bethany Brown and Colleagues Present Recommendations on DEHP Alternatives
-
Oct 30, 2025, 07:52Haemophilia B - An illustrative review of current challenges and opportunities
-
Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
-
Oct 29, 2025, 07:39Pablo Corral: Pushing the Limits of LDLc: Emerging Paradigms in CV Risk Reduction
-
Oct 29, 2025, 07:38Thijs van Haaps and Team Show That Andexanet Alfa May Go Beyond Apixaban and Rivaroxaban
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 1, 2025, 17:04Ozlem Fidanci: Recognizing The Signs of a Stroke Can Save Someone You Love
-
Nov 1, 2025, 15:51Gülşah Türkoğlu: On World Stroke Day, We Came Together to Commemorate This Important Global Health Occasion
-
Nov 1, 2025, 15:05Nusaiba Masnurah Delivered A Speech on Surviving Thrombotic Events Werfen’s EEMEA Seminars
-
Nov 1, 2025, 14:47Rob Verhaeren at WSC 2025: Discover How Philips Technology Helps Accelerate Stroke Response
-
Nov 1, 2025, 13:58Rena Hirani Awarded the Inaugural James Isbister Prize at the Blood ISBT 2025